However, recent analysis using up-to-date differential diagnostic criteria suggests that KRAS mutations do not occur in pure pulmonary squamous cell lung carcinomas, and in case detected, it is confined to LADC components in squamous cancer [15]. This evidence concerns the gene KRAS and squamous cell lung carcinoma.